Polypectomy is adequate treatment for adenoma-like dysplastic lesions (DALMs) in Crohn's Disease

Inflammatory Bowel Diseases

Volumn 19, Issue 6, 2013, Pages 1186-1193

  Quinn, Andrew M ^a   Farraye, Francis A ^b   Naini, Bita V ^c   Cerda, Sandra ^b   Coukos, Jennifer ^b   Li, Yuan ^d   Khor, Tze ^d   Odze, Robert D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adenocarcinoma; Adenoma like DALM; Crohn's disease; Dysplasia; Polyp

Indexed keywords

ADENOMA LIKE DYSPLASTIC LESION; ADULT; AGED; CLINICAL ARTICLE; CLINICAL FEATURE; COLON ADENOCARCINOMA; COLON DISEASE; COLON POLYP; COLON RESECTION; COLONOSCOPY; CONFERENCE PAPER; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CROHN DISEASE; DISEASE DURATION; DYSPLASIA; ENDOSCOPY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; ILEUM DISEASE; MALE; OUTCOME ASSESSMENT; POLYPECTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLONIC DISEASES; COLONIC POLYPS; COLONOSCOPY; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILEAL DISEASES; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84879226796     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e318280e749     Document Type: Conference Paper

References (29)

1. Farraye FA, Odze RD, Eaden J, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:746-774, 774 e1-4; quiz e12-3.
2. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91: 854-862.
3. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994;35:950-954.
4. Ekbom A, Helmick C, Zack M, et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet. 1990;336:357-359.
5. Gillen CD, Walmsley RS, Prior P, et al. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994;35:1590-1592.
6. Ullman TA. Dysplasia and colorectal cancer in Crohn's disease. J Clin Gastroenterol. 2003;36:S75-S78; discussion S94-6.
7. Friedman S, Rubin PH, Bodian C, et al. Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol. 2008;6:993-998; quiz 953-954.
8. Basseri RJ, Basseri B, Vassilaki ME, et al. Colorectal cancer screening and surveillance in Crohn's colitis. J Crohns Colitis. 2012;6:824-829.
9. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931-968.
10. Friedman S, Odze RD, Farraye FA. Management of neoplastic polyps in inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:260-266.
11. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology. 1999;117:1288-1294; discussion 1488-1491.
12. Odze RD, Farraye FA, Hecht JL, et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol. 2004;2:534-541.
13. Rubin PH, Friedman S, Harpaz N, et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology. 1999;117:1295-1300.
14. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
15. Gollop JH, Phillips SF, Melton LJ III, et al. Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut. 1988;29:49-56.
16. Greenstein AJ, Sachar DB, Smith H, et al. A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer. 1981;48:2742-2745.
17. Gyde SN, Prior P, Macartney JC, et al. Malignancy in Crohn's disease. Gut. 1980;21:1024-1029.
18. Munkholm P, Langholz E, Davidsen M, et al. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology. 1993;105: 1716-1723.
19. Petras RE, Mir-Madjlessi SH, Farmer RG Crohn's disease and intestinal carcinoma. A report of 11 cases with emphasis on associated epithelial dysplasia. Gastroenterology. 1987;93:1307-1314.
20. Richards ME, Rickert RR, Nance FC. Crohn's disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease. Ann Surg. 1989;209:764-773.
21. Sigel JE, Petras RE, Lashner BA, et al. Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia. Am J Surg Pathol. 1999;23:651-655.
22. Stahl TJ, Schoetz DJ Jr, Roberts PL, et al. Crohn's disease and carcinoma: increasing justification for surveillance? Dis Colon Rectum. 1992;35: 850-856.
23. Hamilton SR. Colorectal carcinoma in patients with Crohn's disease. Gastroenterology. 1985;89:398-407.
24. Kisiel JB, Loftus EV Jr, Harmsen WS, et al. Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy. Inflamm Bowel Dis. 2012;18:226-235.
25. Vieth M, Behrens H, Stolte M. Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment. Gut. 2006;55:1151-1155.
26. Thomas T, Abrams KA, Robinson RJ, et al. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25:657-668.
27. Fogt F, Vortmeyer AO, Stolte M, et al. Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas. Hum Pathol. 1998;29:961-964.
28. Torres C, Antonioli D, Odze RD. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients. Am J Surg Pathol. 1998;22:275-284.
29. Walsh SV, Loda M, Torres CM, et al. P53 and beta catenin expression in chronic ulcerative colitis - associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. Am J Surg Pathol. 1999;23: 963-969.